Nowadays I spend much of my time at work on the purification of proteins which regulate angiogenesis and lymphangiogenesis.
Image by Michael JeltschNowadays I spend much of my time at work on the purification of proteins which regulate
angiogenesis and lymphangiogenesis
. Therefore, I am taking care of the necessary machinery that the
Molecular Cancer Biology Research Program
owns: the fast protein liquid chromatography (FPLC) machine.
Prof. Jorma Keski-Oja
acquired about 15 years ago one of the first (and in 2010 discontinued) Äkta Explorer machines from Swedish producer
Pharmacia
(who merged in 1997 with
Amersham
to become Amersham Pharmacia Biotech, who was in turn bought by
GE Healthcare
in 2004). In the year 2000 the equipment moved from the
Haartman Institute
into the
Biomedicum Helsinki
. While I have maintained web pages for this piece of research infrastructure for the last five years (including online reservation and data backup), they were only available from inside the
Helsinki University
network.Now, I managed to have
web pages about the Äkta Explorer FPLC core facility
added to the web site of the
Medical Faculty
. At the moment, we are adding the
WAVE cell culture system
to our facility to be able to produce large amounts of cells/cell culture supernatant (up to 25 liters of bacterial, insect or mammalian cell culture) for protein production.
